IHT Wealth Management LLC bought a new stake in Baxter International Inc (NYSE:BAX) in the third quarter, Holdings Channel.com reports. The institutional investor bought 3,639 shares of the medical instruments supplier’s stock, valued at approximately $318,000.
Other hedge funds have also bought and sold shares of the company. Cleararc Capital Inc. lifted its stake in shares of Baxter International by 8.3% in the 3rd quarter. Cleararc Capital Inc. now owns 7,702 shares of the medical instruments supplier’s stock valued at $674,000 after purchasing an additional 591 shares during the last quarter. GQ Asset Management LLC acquired a new position in Baxter International during the third quarter worth $170,000. Amussen Hunsaker Associates LLC increased its position in Baxter International by 73.7% during the third quarter. Amussen Hunsaker Associates LLC now owns 7,666 shares of the medical instruments supplier’s stock worth $671,000 after buying an additional 3,253 shares during the last quarter. National Pension Service raised its holdings in Baxter International by 5.0% during the third quarter. National Pension Service now owns 615,634 shares of the medical instruments supplier’s stock valued at $53,850,000 after buying an additional 29,241 shares in the last quarter. Finally, Adalta Capital Management LLC raised its holdings in Baxter International by 6.9% during the third quarter. Adalta Capital Management LLC now owns 17,075 shares of the medical instruments supplier’s stock valued at $1,497,000 after buying an additional 1,100 shares in the last quarter. 82.43% of the stock is owned by institutional investors.
Several analysts have recently issued reports on BAX shares. Piper Jaffray Companies reiterated a “buy” rating on shares of Baxter International in a research note on Tuesday, September 10th. ValuEngine downgraded Baxter International from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. set a $94.00 target price on Baxter International and gave the stock a “buy” rating in a report on Tuesday, October 8th. Finally, Deutsche Bank began coverage on Baxter International in a research report on Monday, October 21st. They set a “buy” rating and a $109.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $89.77.
NYSE BAX opened at $81.86 on Tuesday. Baxter International Inc has a twelve month low of $61.40 and a twelve month high of $89.93. The company has a debt-to-equity ratio of 0.72, a quick ratio of 2.10 and a current ratio of 2.78. The stock has a market capitalization of $41.85 billion, a PE ratio of 25.38, a P/E/G ratio of 2.11 and a beta of 0.98. The stock has a 50-day simple moving average of $81.66 and a 200 day simple moving average of $82.72.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, December 6th will be paid a dividend of $0.22 per share. The ex-dividend date of this dividend is Thursday, December 5th. This represents a $0.88 annualized dividend and a yield of 1.08%. Baxter International’s payout ratio is 28.85%.
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.
Recommended Story: What causes a stock to be most active?
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.